Bal Pharma Limited (BOM:524824)
India · Delayed Price · Currency is INR 88.85
+0.13 (0.15%)
At close: Jun 16, 2026
Bal Pharma Market Cap
Bal Pharma has a market cap or net worth of 1.41 billion as of June 17, 2026. Its market cap has decreased by -10.67% in one year.
Market Cap
1.41B
Enterprise Value
2.98B
Revenue
3.12B
Ranking
n/a
PE Ratio
22.49
Stock Price
88.85
Market Cap Chart
Since December 20, 2004, Bal Pharma's market cap has increased from 559.95M to 1.41B, an increase of 152.63%. That is a compound annual growth rate of 4.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 16, 2026 | 1.41B | 21.30% |
| Dec 31, 2025 | 1.17B | -39.96% |
| Dec 31, 2024 | 1.94B | 23.18% |
| Dec 29, 2023 | 1.58B | 10.20% |
| Dec 30, 2022 | 1.43B | -8.67% |
| Dec 31, 2021 | 1.57B | 96.53% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sanjivani Paranteral | 1.81B |
| Oxygenta Pharmaceutical | 1.80B |
| Speciality Medicines | 1.78B |
| Coral Laboratories | 1.75B |
| Bio Medica Laboratories | 1.69B |
| Accretion Pharmaceuticals | 1.53B |
| Parnax Lab | 1.49B |
| Bilcare | 1.41B |